Orthofix Medical Inc. (OFIX)
USD 15.54
(-4.66%)
USD 15.54
(-4.66%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 667.42 Million USD | 70.64% |
| 2022 | 357.84 Million USD | 5.16% |
| 2021 | 340.29 Million USD | 9.26% |
| 2020 | 311.43 Million USD | -9.44% |
| 2019 | 343.92 Million USD | 6.39% |
| 2018 | 323.25 Million USD | 6.87% |
| 2017 | 302.45 Million USD | 6.31% |
| 2016 | 284.49 Million USD | -2.45% |
| 2015 | 291.62 Million USD | 7.76% |
| 2014 | 270.61 Million USD | -0.21% |
| 2013 | 271.18 Million USD | -4.8% |
| 2012 | 284.84 Million USD | -18.81% |
| 2011 | 350.82 Million USD | 2.08% |
| 2010 | 343.66 Million USD | 0.1% |
| 2009 | 343.31 Million USD | -45.04% |
| 2008 | 624.61 Million USD | 106.65% |
| 2007 | 302.26 Million USD | 14.98% |
| 2006 | 262.88 Million USD | 54.81% |
| 2005 | 169.81 Million USD | 11.38% |
| 2004 | 152.46 Million USD | 36.09% |
| 2003 | 112.03 Million USD | 24.71% |
| 2002 | 89.83 Million USD | 1.04% |
| 2001 | 88.9 Million USD | 21.35% |
| 2000 | 73.26 Million USD | 7.94% |
| 1999 | 67.88 Million USD | 8.96% |
| 1998 | 62.3 Million USD | 10.85% |
| 1997 | 56.2 Million USD | 13.54% |
| 1996 | 49.5 Million USD | 84.7% |
| 1995 | 26.8 Million USD | 75.16% |
| 1994 | 15.3 Million USD | 28.57% |
| 1993 | 11.9 Million USD | 1.71% |
| 1992 | 11.7 Million USD | 0.0% |
| 1991 | - USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 152.16 Million USD | 0.65% |
| 2024 Q1 | 151.18 Million USD | -0.03% |
| 2023 Q1 | 165.9 Million USD | 69.39% |
| 2023 FY | 610.62 Million USD | 70.64% |
| 2023 Q2 | 157.48 Million USD | -5.08% |
| 2023 Q3 | 140.64 Million USD | -10.69% |
| 2023 Q4 | 151.22 Million USD | 7.52% |
| 2022 Q1 | 86.67 Million USD | -2.17% |
| 2022 Q3 | 88.79 Million USD | -1.93% |
| 2022 FY | 357.84 Million USD | 5.16% |
| 2022 Q2 | 90.54 Million USD | 4.46% |
| 2022 Q4 | 97.94 Million USD | 10.3% |
| 2021 FY | 340.29 Million USD | 9.26% |
| 2021 Q1 | 80.09 Million USD | -3.0% |
| 2021 Q2 | 90.76 Million USD | 13.32% |
| 2021 Q3 | 86.73 Million USD | -4.44% |
| 2021 Q4 | 88.6 Million USD | 2.15% |
| 2020 Q3 | 79.42 Million USD | 18.04% |
| 2020 Q1 | 82.14 Million USD | -7.57% |
| 2020 Q4 | 82.57 Million USD | 3.96% |
| 2020 FY | 311.43 Million USD | -9.44% |
| 2020 Q2 | 67.29 Million USD | -18.08% |
| 2019 Q1 | 83.39 Million USD | 0.88% |
| 2019 Q2 | 87.77 Million USD | 5.26% |
| 2019 Q3 | 83.87 Million USD | -4.45% |
| 2019 Q4 | 88.86 Million USD | 5.95% |
| 2019 FY | 343.92 Million USD | 6.39% |
| 2018 Q4 | 82.67 Million USD | 0.57% |
| 2018 FY | 323.25 Million USD | 6.87% |
| 2018 Q2 | 81.68 Million USD | 6.52% |
| 2018 Q3 | 82.2 Million USD | 0.63% |
| 2018 Q1 | 76.68 Million USD | -3.91% |
| 2017 Q1 | 74.23 Million USD | -3.93% |
| 2017 Q4 | 79.8 Million USD | 10.09% |
| 2017 Q3 | 72.49 Million USD | -6.78% |
| 2017 FY | 302.45 Million USD | 6.31% |
| 2017 Q2 | 77.76 Million USD | 4.75% |
| 2016 FY | 284.49 Million USD | -2.45% |
| 2016 Q4 | 77.27 Million USD | 15.07% |
| 2016 Q1 | 69.17 Million USD | -9.02% |
| 2016 Q3 | 67.15 Million USD | -5.12% |
| 2016 Q2 | 70.78 Million USD | 2.33% |
| 2015 Q3 | 72 Million USD | 0.13% |
| 2015 Q1 | 71.69 Million USD | -0.72% |
| 2015 FY | 291.62 Million USD | 7.76% |
| 2015 Q2 | 71.9 Million USD | 0.28% |
| 2015 Q4 | 76.02 Million USD | 5.59% |
| 2014 Q1 | 67.93 Million USD | -2.56% |
| 2014 Q4 | 72.21 Million USD | 7.96% |
| 2014 Q2 | 66.54 Million USD | -2.06% |
| 2014 FY | 270.61 Million USD | -0.21% |
| 2014 Q3 | 66.89 Million USD | 0.53% |
| 2013 Q3 | 62.56 Million USD | -9.63% |
| 2013 FY | 271.18 Million USD | -4.8% |
| 2013 Q4 | 69.72 Million USD | 11.45% |
| 2013 Q2 | 69.23 Million USD | -5.85% |
| 2013 Q1 | 73.53 Million USD | 6.93% |
| 2012 Q4 | 68.76 Million USD | -2.93% |
| 2012 FY | 284.84 Million USD | -18.81% |
| 2012 Q1 | 88.21 Million USD | -0.84% |
| 2012 Q2 | 73.88 Million USD | -16.24% |
| 2012 Q3 | 70.84 Million USD | -4.12% |
| 2011 FY | 350.82 Million USD | 2.08% |
| 2011 Q4 | 88.96 Million USD | 3.81% |
| 2011 Q2 | 90.28 Million USD | -31.53% |
| 2011 Q3 | 85.7 Million USD | -5.08% |
| 2011 Q1 | 131.86 Million USD | 39.86% |
| 2010 FY | 343.66 Million USD | 0.1% |
| 2010 Q4 | 94.28 Million USD | 7.58% |
| 2010 Q1 | 86.73 Million USD | 1.7% |
| 2010 Q2 | 87.54 Million USD | 0.94% |
| 2010 Q3 | 87.64 Million USD | 0.11% |
| 2009 Q4 | 85.28 Million USD | -0.09% |
| 2009 Q3 | 85.36 Million USD | -1.87% |
| 2009 Q1 | 85.66 Million USD | -2.8% |
| 2009 Q2 | 86.99 Million USD | 1.55% |
| 2009 FY | 343.31 Million USD | -45.04% |
| 2008 Q4 | 88.13 Million USD | -76.23% |
| 2008 Q1 | 82.2 Million USD | 0.65% |
| 2008 Q2 | 83.45 Million USD | 1.52% |
| 2008 FY | 624.61 Million USD | 106.65% |
| 2008 Q3 | 370.82 Million USD | 344.34% |
| 2007 FY | 302.26 Million USD | 14.98% |
| 2007 Q4 | 81.67 Million USD | 9.5% |
| 2007 Q1 | 71.29 Million USD | -3.13% |
| 2007 Q3 | 74.58 Million USD | -0.16% |
| 2007 Q2 | 74.71 Million USD | 4.79% |
| 2006 Q2 | 48.46 Million USD | 0.98% |
| 2006 FY | 262.88 Million USD | 54.81% |
| 2006 Q4 | 73.6 Million USD | -20.7% |
| 2006 Q1 | 47.99 Million USD | 6.35% |
| 2006 Q3 | 92.81 Million USD | 91.52% |
| 2005 Q2 | 42.19 Million USD | 2.46% |
| 2005 FY | 169.81 Million USD | 11.38% |
| 2005 Q4 | 45.13 Million USD | 7.95% |
| 2005 Q3 | 41.8 Million USD | -0.91% |
| 2005 Q1 | 41.18 Million USD | 5.99% |
| 2004 Q1 | 38.4 Million USD | 36.67% |
| 2004 Q3 | 37.3 Million USD | -1.55% |
| 2004 Q2 | 37.89 Million USD | -1.33% |
| 2004 Q4 | 38.85 Million USD | 4.15% |
| 2004 FY | 152.46 Million USD | 36.09% |
| 2003 Q3 | 29.94 Million USD | 6.43% |
| 2003 FY | 112.03 Million USD | 24.71% |
| 2003 Q1 | 25.85 Million USD | 13.27% |
| 2003 Q2 | 28.13 Million USD | 8.83% |
| 2003 Q4 | 28.1 Million USD | -6.16% |
| 2002 Q3 | 23.06 Million USD | 2.84% |
| 2002 Q1 | 21.52 Million USD | 116.32% |
| 2002 Q2 | 22.42 Million USD | 4.17% |
| 2002 FY | 89.83 Million USD | 1.04% |
| 2002 Q4 | 22.82 Million USD | -1.02% |
| 2001 Q4 | -131.86 Million USD | 0.0% |
| 2001 Q3 | - USD | -100.0% |
| 2001 Q1 | 20.8 Million USD | 1.53% |
| 2001 Q2 | 22.18 Million USD | 6.63% |
| 2001 FY | 88.9 Million USD | 21.35% |
| 2000 Q1 | 17.68 Million USD | -10.6% |
| 2000 Q4 | 20.48 Million USD | 17.03% |
| 2000 Q3 | 17.5 Million USD | -0.47% |
| 2000 FY | 73.26 Million USD | 7.94% |
| 2000 Q2 | 17.58 Million USD | -0.54% |
| 1999 FY | 67.88 Million USD | 8.96% |
| 1999 Q2 | 16.5 Million USD | 4.43% |
| 1999 Q4 | 19.78 Million USD | 25.2% |
| 1999 Q3 | 15.8 Million USD | -4.24% |
| 1999 Q1 | 15.8 Million USD | 117.79% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | 62.3 Million USD | 10.85% |
| 1998 Q4 | -88.8 Million USD | 0.0% |
| 1998 Q1 | - USD | 100.0% |
| 1998 Q2 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | 56.2 Million USD | 13.54% |
| 1997 Q4 | -78.9 Million USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q1 | - USD | 100.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q4 | -70.6 Million USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 FY | 49.5 Million USD | 84.7% |
| 1996 Q1 | - USD | 100.0% |
| 1995 FY | 26.8 Million USD | 75.16% |
| 1995 Q4 | -44.8 Million USD | 0.0% |
| 1995 Q1 | 4.2 Million USD | 115.0% |
| 1995 Q2 | - USD | -100.0% |
| 1995 Q3 | - USD | 0.0% |
| 1994 Q4 | -28 Million USD | 0.0% |
| 1994 Q2 | 3.8 Million USD | 0.0% |
| 1994 Q1 | - USD | 100.0% |
| 1994 FY | 15.3 Million USD | 28.57% |
| 1994 Q3 | - USD | -100.0% |
| 1993 Q4 | -20.8 Million USD | 0.0% |
| 1993 FY | 11.9 Million USD | 1.71% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 100.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 FY | 11.7 Million USD | 0.0% |
| 1992 Q4 | -19.7 Million USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -5846.427% |
| Cerus Corporation | 143.15 Million USD | -366.227% |
| OrthoPediatrics Corp. | 137.01 Million USD | -387.105% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -5774.79% |
| Talis Biomedical Corporation | 67.18 Million USD | -893.402% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -2575.487% |
| Inogen, Inc. | 236.08 Million USD | -182.706% |
| Spectral AI, Inc. | 20.86 Million USD | -3098.941% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -1091.898% |
| CVRx, Inc. | 76.14 Million USD | -776.556% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -18818.02% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -5244.119% |
| Venus Concept Inc. | 80.47 Million USD | -729.349% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -1079.658% |
| Bioventus Inc. | 409.91 Million USD | -62.82% |
| BrainsWay Ltd. | 28.01 Million USD | -2282.136% |
| Envoy Medical, Inc. | 17.89 Million USD | -3629.059% |
| electroCore, Inc. | 32.03 Million USD | -1983.691% |
| IceCure Medical Ltd | 16.87 Million USD | -3854.889% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -1472.933% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -3685.096% |
| MaxCyte, Inc. | 84.84 Million USD | -686.643% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -5277.373% |
| Nexalin Technology, Inc. | 5.78 Million USD | -11444.472% |
| PAVmed Inc | 64.82 Million USD | -929.551% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -1206.682% |
| RxSight, Inc. | 103.85 Million USD | -542.684% |
| Sight Sciences, Inc. | 126.44 Million USD | -427.823% |
| SI-BONE, Inc. | 156.35 Million USD | -326.877% |
| TELA Bio, Inc. | 84.18 Million USD | -692.791% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -852.705% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -228.192% |
| LivaNova PLC | 843.54 Million USD | 20.879% |
| 908 Devices Inc. | 68.08 Million USD | -880.357% |
| Alphatec Holdings, Inc. | 483.59 Million USD | -38.013% |
| Nemaura Medical Inc. | 7.13 Million USD | -9249.284% |
| NeuroPace, Inc. | 75.29 Million USD | -786.404% |
| LENSAR, Inc. | 33.33 Million USD | -1902.121% |
| Apyx Medical Corporation | 51.01 Million USD | -1208.219% |
| Cutera, Inc. | 197.72 Million USD | -237.555% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -2593.301% |
| BioSig Technologies, Inc. | 28.53 Million USD | -2239.387% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -248.571% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -1750.879% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 20.202% |
| Axonics, Inc. | 270.2 Million USD | -147.01% |
| Outset Medical, Inc. | 198.77 Million USD | -235.779% |
| IRIDEX Corporation | 31.81 Million USD | -1997.903% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -270.342% |
| IRadimed Corporation | 30.12 Million USD | -2115.686% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -7722.632% |
| INVO Bioscience, Inc. | 7.85 Million USD | -8398.69% |
| Telesis Bio, Inc. | 63.48 Million USD | -951.248% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -577.914% |
| Varex Imaging Corporation | 224.8 Million USD | -196.898% |
| Quipt Home Medical Corp. | 148.66 Million USD | -348.941% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -5593.312% |
| Pulmonx Corporation | 112.68 Million USD | -492.284% |
| Dynatronics Corporation | 9.9 Million USD | -6636.226% |
| Modular Medical, Inc. | 17.52 Million USD | -3707.559% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -3206.222% |
| Semler Scientific, Inc. | 38.94 Million USD | -1613.812% |
| InMode Ltd. | 215.68 Million USD | -209.452% |
| Bruker Corporation | 1.07 Billion USD | 37.995% |
| Cytosorbents Corporation | 48.33 Million USD | -1280.783% |
| DexCom, Inc. | 1.69 Billion USD | 60.535% |
| Align Technology, Inc. | 2.07 Billion USD | 67.863% |
| Viveve Medical, Inc. | 22.17 Million USD | -2910.089% |
| ZimVie Inc. | 275.12 Million USD | -142.59% |
| Movano Inc. | 29.69 Million USD | -2147.986% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -386.211% |
| Nexalin Technology, Inc. | 5.78 Million USD | -11444.472% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -18818.02% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | -11.068% |
| Profound Medical Corp. | 33.6 Million USD | -1886.204% |
| Insulet Corporation | 939.9 Million USD | 28.99% |
| enVVeno Medical Corporation | 25.23 Million USD | -2544.532% |
| Surmodics, Inc. | 98.69 Million USD | -576.238% |
| iCAD, Inc. | 22.22 Million USD | -2903.046% |
| Nuwellis, Inc. | 22.61 Million USD | -2851.519% |
| Biotricity, Inc. | 17.18 Million USD | -3783.878% |
| iRhythm Technologies, Inc. | 445.88 Million USD | -49.685% |
| Aethlon Medical, Inc. | 12.27 Million USD | -5336.175% |
| InspireMD, Inc. | 22.95 Million USD | -2808.179% |
| PAVmed Inc. | 64.82 Million USD | -929.551% |
| BIOLASE, Inc. | 34.66 Million USD | -1825.585% |
| Beyond Air, Inc. | 61.7 Million USD | -981.729% |
| FONAR Corporation | 28.6 Million USD | -2233.279% |
| AxoGen, Inc. | 149.33 Million USD | -346.93% |
| Vivani Medical, Inc. | 26.96 Million USD | -2375.16% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -276.882% |
| Inari Medical, Inc. | 448.59 Million USD | -48.781% |
| UFP Technologies, Inc. | 58.08 Million USD | -1048.973% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -13444.67% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -10463.414% |
| Tenon Medical, Inc. | 16.96 Million USD | -3833.445% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -8927.824% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -1413.342% |
| AdaptHealth Corp. | 1.07 Billion USD | 38.085% |
| Sintx Technologies, Inc. | 15.2 Million USD | -4290.678% |
| NanoVibronix, Inc. | 4.97 Million USD | -13321.013% |
| Quanterix Corporation | 118.1 Million USD | -465.137% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -5593.312% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -4521.431% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | -69.973% |
| TransMedics Group, Inc. | 182.82 Million USD | -265.073% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -2278.147% |
| NeuroMetrix, Inc. | 11.09 Million USD | -5913.433% |
| Hyperfine, Inc. | 52.87 Million USD | -1162.345% |
| Establishment Labs Holdings Inc. | 172 Million USD | -288.032% |
| Biomerica, Inc. | 6.97 Million USD | -9464.732% |
| Bone Biologics Corporation | 9.42 Million USD | -6978.973% |
| AVITA Medical, Inc. | 80.77 Million USD | -726.236% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -6372.825% |
| Silk Road Medical, Inc | 186.35 Million USD | -258.144% |